SPX4,158.25+100.41 2.47%
DIA332.13+5.68 1.74%
IXIC12,131.13+390.48 3.33%

Antibe Therapeutics Details Strategic Sale of Citagenix Subsidiary For $6.5 Million Cash

MT Newswires · 05/02/2022 04:06

Please log in to view news